Preparation of 1,4-Oxaselenin from AgNO3/LDA-Assisted Reaction of 3-Selena-4-pentyn-1-one as Potential Antitumor Agents

Organic Letters

Volumn 3, Issue 11, 2001, Pages 1705-1707

  Koketsu, Mamoru ^a   Yang, Hyun Ok ^b   Kim, Yong Man ^c   Ichihashi, Michiko ^a   Ishihara, Hideharu ^a  

^a GIFU UNIVERSITY   (Japan)

^b University of Ulsan   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 OXASELENIN; 1,4-OXASELENIN; 3 SELENA 4 PENTYN 1 ONE; 3-SELENA-4-PENTYN-1-ONE; ANTINEOPLASTIC AGENT; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; SELENIUM DERIVATIVE; SILVER NITRATE;

ARTICLE; CHEMISTRY; SYNTHESIS;

ANTINEOPLASTIC AGENTS; INDICATORS AND REAGENTS; SELENIUM COMPOUNDS; SILVER NITRATE;

EID: 0035979081     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol015897z     Document Type: Article

References (46)

1. (a) Ogawa, A.; Sonoda, N. Rev. Heteroat. Chem. 1994, 10, 43.
2. (b) Guziec, F. S., Jr.; Guziec, L. J. In Comprehensive Organic Functional Group Transformations; Katritzky, A. R., Meth-Cohn, O., Rees, C. W., Eds.; Pergamon: Oxford, 1995; Vol. 3, p 381.
3. (c) Krief, A. In Comprehensive Organometallic Chemistry; Abel, W. W., Stone, F. G. A., Wilkinson, G., Eds.; Pergamon: Oxford, 1995; Vol. 11, p 515.
4. (d) Koketsu, M.; Hiramatsu, S.; Ishihara, H. Chem. Lett. 1999, 485.
5. (e) Back, T. G. Organoselenium Chemistry: A Practical Approach; Oxford University Press: U.K., 1999.
6. (f) Koketsu, M.; Suzuki, N.; Ishihara, H. J. Org. Chem. 1999, 64, 6473.
7. (g) Wirth, T. Organoselenium Chemistry. Modern Developments in Organic Synthesis; Springer, 2000.
8. (a) Clement, I.; Lisk, D. J.; Ganther, H. E. Anticancer Res. 1998, 18, 4019.
9. (b) May, S. W.; Pollock, S. H. Drugs 1998, 56, 959.
10. (c) Koketsu, M.; Ishihara, H.; Wu, W.; Murakami, K.; Saiki, I. Eur. J. Pharm. Sci. 1999, 9, 157.
11. (d) Wu, W.; Murakami, K.; Koketsu, M.; Yamada, Y.; Saiki, I. Anticancer Res. 1999, 19, 5375.
12. (e) May, S. W. Expert Opin. Invest. Drugs 1999, 8, 1017.
13. (f) Page, K.; Li, J.; Hodge, J. A.; Liu, P. T.; Hoek, T. L. V.; Becker, L. B.; Pestell, R. G.; Rosner, M. R.; Hershenson, M. B. J. Biol. Chem. 1999, 274, 22065.
14. (g) Zhu, Z.; Jiang, W.; Ganther, H. E. Ip, C.; Thompson, H. J. Biochem. Pharmacol. 2000, 60, 1467.
15. (h) Cho, S. I.; Koketsu, M.; Ishihara, H.; Matsushita, M.; Nairn, A. C.; Fukazawa, H.; Uehara, Y. Biochim. Biophys. Acta 2000, 1475, 207.
16. (i) Ostrovidov, S.; Franck, P.; Joseph, D.; Martarello, L.; Kirsch, G.; Belleville, F.; Nabet, P.; Dousset, B. J. Med. Chem. 2000, 43, 1762.
17. Lucas, M. A.; Carl, H. S. J. Org. Chem. 1998, 63, 3032.
18. Kataoka, T.; Watanabe, S.; Yamamoto, K.; Yoshimatsu, M.; Tanabe, G.; Muraoka, O. J. Org. Chem. 1998, 63, 6382.
19. Okuma, K.; Kojima, K.; Kaneko, I.; Tsujimoto, Y.; Ohta, H.; Yokomori, Y. J. Chem. Soc., Perkin Trans. 1 1994, 2151.
20. These examples were for 1,4-oxaselenins with different structures from different starting materials. Reported as 3,5-disubstituted 2,5-dihydro-1,4-oxaselenin; (a) Migalina, Y. V.; Staninets, V. I.; Lendel, V. G.; Balog, I. M.; Palyulin, V. A.; Koz'min, A. S.; Zefirov, N. S. Khim. Geterotsikl. Soedin. 1977, 58; Chem. Abstr. 1977, 86, 189862x. Reported as 3,5- disubstituted 1,4-oxaselenin:
21. These examples were for 1,4-oxaselenins with different structures from different starting materials. Reported as 3,5-disubstituted 2,5-dihydro- 1,4-oxaselenin; (a) Migalina, Y. V.; Staninets, V. I.; Lendel, V. G.; Balog, I. M.; Palyulin, V. A.; Koz'min, A. S.; Zefirov, N. S. Khim. Geterotsikl. Soedin. 1977, 58; Chem. Abstr. 1977, 86, 189862x. Reported as 3,5-disubstituted 1,4-oxaselenin:
22. (b) Migalina, Y. V.; Lendel, V. Y.; Staninets, V. I. Ukr. Khim. Zh. (Russ. Ed.) 1980, 46, 640; Chem. Abstr. 1980, 93, 204592z.
23. (b) Migalina, Y. V.; Lendel, V. Y.; Staninets, V. I. Ukr. Khim. Zh. (Russ. Ed.) 1980, 46, 640; Chem. Abstr. 1980, 93, 204592z.
24. Koketsu, M.; Kanoh, M.; Itoh, E.; Ishihara, H. J. Org. Chem., in press.
25. (a) Shimada, K.; Akimoto, S.; Itoh, H.; Nakamura, H.; Takikawa, Y. Chem. Lett. 1994, 1743.
26. (b) Shimada, K.; Akimoto, S.; Takikawa, Y.; Kabuto, C. Chem. Lett. 1994, 2283.
27. (c) Murai, T.; Ezaka, T.; Kanda, T.; Kato, S. Chem. Commun. 1996, 1809.
28. (d) Watanabe, S.; Mori, E.; Nagai, H.; Kataoka, T. Synlett 2000, 49.
29. The use of other Ag(I) reagents could not improve the yield of 5a.
30. (a) Yu, Y.; Yamanaka, M.; Nakamura, E. Org. Lett. 1999, 1, 407.
31. (b) Iwamatsu, S.; Matsubara, K.; Nagashima, H. J. Org. Chem. 1999, 64, 9625.
32. (c) Campo, F. D.; Lastécouères, D.; Vincent, J.-M. Verlhac, J.-B. J. Org. Chem. 1999, 64, 4969.
33. (d) Fitzgerald, J. P.; Nanda, H.; Fitzgerald, P. Yee, G. T. J. Org. Chem. 2000, 65, 2222.
34. (e) García-Frutos, E. M.; Fernândez-Lázaro, F.; Maya, E. M.; Vázquez, P.; Torres, T. J. Org. Chem. 2000, 65, 6841.
35. (f) Erdelmeier, I.; Tailhan-Lomont, C.; Yadan, J.-C. J. Org. Chem. 2000, 65, 8152.
36. (g) Nagashima, H.; Isono, Y.; Iwamatsu, S. J. Org. Chem. 2001, 66, 315.
37. (a) Suzuki, H.; Shinoda, M. Synthesis 1977, 640.
38. (b) Suzuki, H.; Miyoshi, K.; Shinoda, M. Bull. Chem. Soc. Jpn. 1980, 53, 1765.
39. (c) Lindley, J. Tetraherdon 1984, 40, 1433.
40. (d) Peng, S.; Qing. F.-L.; Li, Y.-Q.; Hu, C.-M. J. Org. Chem. 2000, 65, 694.
41. (a) Baldwin, J. E. J. Chem. Soc., Chem. Commun. 1976, 734.
42. (b) Baldwin, J. E.; Cutting, J.; Dupont, W.; Kruse, L.; Silberman, L.; Thomas, R. C. J. Chem. Soc., Chem. Commun. 1976, 736.
43. Short, K. M.; Ziegler, C. B., Jr. Tetraheron Lett. 1993, 34, 75.
44. (a) Koh, J. Y.; Choi, S. W. J. Neurosci. Methods 1987, 20, 83.
45. (b) Vermes, I.; Haanen, C. Steffens-Nakken, H.; Reutelingsperger. C. J. Immunol. Methods 1995 184, 39.
46. (C) Vermes, I.; Haanen, C. Steffens-Nakken, H.; Reutelingsperger. C. J. Immunol. Methods 2000 243, 167.